As states begin to explore “reopening” in various ways, and providers and payers struggle with not only how to directly care for those impacted, but also how to ensure that their other patients or members receive needed care, the role of quality and population health will continue to evolve.
Many experts suggest that the COVID-19 pandemic illustrated the fragility of a volume-based delivery system and contend that a value-based system predicated on quality will evolve more quickly as a result. Others point out that a population health infrastructure and approach is the only way to properly align care for those who need it, when they need it, amidst a delivery system with limited capacity. SPH Analytics is proud to host front-line leaders in an interactive panel discussion about their views on the role of quality measurement and population health in a post-COVID world.
Moderator: Kevin Weinstein, SPH Analytics
- Dr. Joel Shu, Chief Medical Officer & Chief Quality Officer, Emory Healthcare Network
- Dr. Amy Helwig, Vice President, Quality Improvement and Performance, UPMC
- Dan Marino, Managing Partner, Lumina Health Partners